Search

everythinglearnresearchcommunity

for

Search:↓

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Tamoxifen caused hair loss in a 52-year-old woman.

Scalp Roller therapy helped improve hair growth in patients with hard-to-treat alopecia areata.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

White and yellow dots indicate severe female hair loss in dark skin.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Temporal hair loss relates to overall scalp hair loss in women.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Scalp massages may help stabilize or regrow hair in people suffering from hair loss, regardless of age, gender, or use of other treatments.

Hair transplant surgery is the most effective, safe, and satisfying treatment for hair loss.

People with alopecia areata often have lower vitamin D levels than healthy people.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The report concludes that atypical Brauer nevus is more common in males, present at birth, and often misdiagnosed due to its unusual scalp locations.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

A 62-year-old woman with hair loss and skin condition had successful hair transplant surgery lasting 6 years, and medications helped reduce hair fall and promote growth.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Receding hairlines in men are uneven, with the right side larger than the left.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

PGD2 stops hair growth and is higher in bald men with AGA.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.